ID   633
AC   CVCL_E066
SY   Line 633
DR   CLO; CLO_0050068
DR   BioSample; SAMN03471969
DR   cancercelllines; CVCL_E066
DR   RCB; RCB2352
DR   Wikidata; Q54604367
RX   PubMed=10590124;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): RCB=RCB2352
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D5S818: 11
ST   D7S820: 8,11
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U656 ! AE1-2a
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 02-05-24; Version: 14
//
RX   PubMed=10590124; DOI=10.1128/JVI.74.1.354-362.2000;
RA   Von Seggern D.J., Huang S., Fleck S.K., Stevenson S.C., Nemerow G.R.;
RT   "Adenovirus vector pseudotyping in fiber-expressing cell lines:
RT   improved transduction of Epstein-Barr virus-transformed B cells.";
RL   J. Virol. 74:354-362(2000).
//